Amazing Career Opportunities of SCBE Programs
Chemical and Biomolecular Engineering (CBE) graduates can find challenging opportunities in traditional as well as emerging engineering fields such as petrochemicals, bio-pharmaceuticals, specialty chemicals, electronics, process design, energy and utilities, food/flavours/ fragrances, consumer products, nanotechnology, and finance and trading jobs in related industries. Top hirers include Shell, Exxon Mobil, Singapore Refining Company, Roche, Pfizer, Merck, DuPont, BASF, ABB, Coca-Cola, Siemens, General Electric, Keppel, 3M, Procter & Gamble, DBS, J.P. Morgan, Goldman Sachs and many others. More than 90%* of our CBE graduates find job in these companies, who commands high starting monthly salaries of more than S$3270*, while others pursue PhD studies in renowned institution like Harvard-MIT, Cornell University, Yale, University of Cambridge and Duke-NUS Graduate Medical School.
Bioengineering (BIE) graduates who are well-versed in both engineering and biomedical sciences find attractive opportunities in industries, research institutes, hospitals and organisations that deal with biomedical instrumentation, medical devices, biomaterials, drug discovery and others. Bioengineering graduates can find abundant career opportunities in healthcare industries, such as Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Philips Medical, Burker, Glaxo SmithKline, Johnson & Johnson, Boston Scientific, Bayer, Eli Lilly, Baxter, Merck, Procter & Gamble Pharmaceuticals, Novo Nordisk, Gilead Sciences, Singapore General Hospital, and the list goes on. Our BIE graduates have consistently commanded a high starting monthly salary of more than S$3090*.
Singapore is set to become a global biomedical hub, with biomedical companies manufacture about S$21 billion worth of medicines, nutritional products and medical devices for global markets annually. New biomedical companies will continue to integrate their essential business activities across regional headquarters, R&D and manufacturing activities in Singapore, recent one includes Amgen, a company that develops human therapeutics, who chooses Singapore to invest a $200 million innovative new facility (see “Amgen Chooses Singapore for New Manufacturing Plant”), and Novartis, which will invest over $500 million in Singapore (see “Novartis to start construction of new biotechnology facility in Singapore”).
Other top MNCs, such as Halliburton, one of the world’s largest oilfield services companies and a leader in the energy industries, has also opened a new manufacturing centre in Jurong Industrial Park which includes more than 500,000 square feet (46,451 square meters) of manufacturing and administrative space.
These companies will offer rewarding career opportunities to our graduates.